# Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema (PREVENT)

> **NCT02167659** · NA · COMPLETED · sponsor: **ImpediMed Limited** · enrollment: 1201 (actual)

## Conditions studied

- Lymphedema

## Interventions

- **DEVICE:** 23-32 mmHg compression sleeve with gauntlet

## Key facts

- **NCT ID:** NCT02167659
- **Lead sponsor:** ImpediMed Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 1201 (ACTUAL)
- **Last updated:** 2021-01-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02167659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02167659, "Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema (PREVENT)". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT02167659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
